Skip to main content

Animations

MJFF Publications

4601 - 4610 of 6230 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs
    Journal Name: Radiology
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/radiol.2018180940
    Best OA location URL:
    Citation Count: 213
  • Summary Details
    OPEN
    Title: Abstract
    Journal Name: Brain and Neuroscience Advances
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/2398212819855490
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/0271678x19843776
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000924
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Clinical Phenotype of <b><i>LRRK2</i></b> R1441C in 2 Chinese Sisters
    Journal Name: Neurodegenerative Diseases
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000508131
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Genetic risk scores and hallucinations in patients with Parkinson disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000492
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Analysis of common and rare VPS13C variants in late-onset Parkinson disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000385
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000711
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000430
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Antiglutamic Acid Decarboxylase 65 Antibody–Associated Hemiataxia
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000939
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.